Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
Leire de Campos‐Mata, Benjamin Trinité, Andrea Modrego, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination
Julià Blanco, Benjamin Trinité, Joan Puig‐Barberà
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-COV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 5
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 4
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Cyril Planchais, I. Fernández, Benjamin Chalopin, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110354-110354
Open Access | Times Cited: 1
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants
Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants
Léa Dépéry, Isabelle Bally, Axelle Amen, et al.
Microbiology Spectrum (2024) Vol. 13, Iss. 1
Open Access
Plant‐produced SARS‐CoV‐2 antibody engineered towards enhanced potency and in vivo efficacy
Steven W. de Taeye, Loı̈c Faye, Bertrand Morel, et al.
Plant Biotechnology Journal (2024)
Open Access
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches
Daouda Abba Moussa, Mario Vazquez, Christine Chable-Bessia, et al.
Emerging Microbes & Infections (2024) Vol. 14, Iss. 1
Closed Access
Structural Immunology of SARS‐CoV‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access
Effects of SARS-CoV-2 on DNA Damage Response Proteins Chk1 and P53: An in vitro Study
Mahmoud A. Chawsheen, Habiba Mohamed Hassan, Ahmed A. Al-Naqshbandi, et al.
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 7, Iss. 2, pp. 151-156
Closed Access
Page 1

Scroll to top